GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Red White & Bloom Brands Inc (OTCPK:RWBYF) » Definitions » Beta

Red White & Bloom Brands (Red White & Bloom Brands) Beta : N/A (As of May. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Red White & Bloom Brands Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-14), Red White & Bloom Brands's Beta is Not available.


Red White & Bloom Brands Beta Historical Data

The historical data trend for Red White & Bloom Brands's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Red White & Bloom Brands Beta Chart

Red White & Bloom Brands Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beta
- - - - -

Red White & Bloom Brands Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.40 - -

Competitive Comparison of Red White & Bloom Brands's Beta

For the Drug Manufacturers - Specialty & Generic subindustry, Red White & Bloom Brands's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Red White & Bloom Brands's Beta Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Red White & Bloom Brands's Beta distribution charts can be found below:

* The bar in red indicates where Red White & Bloom Brands's Beta falls into.



Red White & Bloom Brands Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Red White & Bloom Brands  (OTCPK:RWBYF) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Red White & Bloom Brands Beta Related Terms

Thank you for viewing the detailed overview of Red White & Bloom Brands's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Red White & Bloom Brands (Red White & Bloom Brands) Business Description

Traded in Other Exchanges
Address
789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2
Red White & Bloom Brands Inc is a multi-state operator in the United States conducting operations in the legal cannabis industry. The principal activity of the company is the sale of a diverse range of high-quality cannabis-based products delivered through its distribution and retail channels. The company operates twelve licensed adult-use and medical retail dispensaries located in the legal states of Michigan and Florida.